Immunological Data Discovery Index
Immunological Data Discovery Index
Associating Renal Transplantation With the ITN Signature of Tolerance ITN TrialShare
ID: ITN524ST
Description: This study is for people who will receive a kidney transplant from a very well matched, living blood relative. After receiving a kidney transplant, a ...
Publication: 28371372; 20501946;Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies ITN TrialShare
ID: ITN019AD
Description: This Phase II double-blinded, parallel group, multi-center, placebo-controlled study examined whether pre-treatment of participants with Omalizumab fo...
Publication: 17631952; 16387596; 14619332;Study of Tolerant Kidney Transplant Recipients ITN TrialShare
ID: ITN507ST
Description: Grant: National Institute of Allergy and Infectious Diseases This is a registry trial collecting extensive demographic and clinical information, medic...
Publication: 26461968; 22151236; 20501946; 20501950; 19050058; 15257060;Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study ITN TrialShare
ID: ITN025AD
Description: Researchers suspect that allergies to common inhaled allergens (such as house dust mite, cat dander, and grass pollens) are a major cause of childhood...
Publication: 23768574; 16701145; 16675331;Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults ITN TrialShare
ID: ITN013ST
Description: Alemtuzumab (Campath-1H) is a man-made antibody used to treat certain blood disorders. The purpose of this study is to test the safety and effectivene...
Publication: 19344431; 15599882; 12079485; 15888040;Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients ITN TrialShare
ID: ITN022ST
Description: Alemtuzumab (Campath-1H) is a man-made antibody used to treat certain blood disorders. This study will evaluate treatment of kidney transplant recipie...
Publication: 23903014;Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis ITN TrialShare
ID: ITN020AI
Description: This is a phase II, double blind, placebo-controlled, multicenter, randomized study of the efficacy and safety of atorvastatin (80 mg/day) in particip...
Publication: 22459680;Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients ITN TrialShare
ID: ITN029ST
Description: This is a prospective multicenter, open-label, single-arm trial in which 20 pediatric recipients of parental living-donor liver allografts will underg...
Publication: 25648649; 22253395; 16433002; 27302659;